Gary K. Lee Lyell Immunopharma, Inc. (LYEL) insider trading activity
Gary K. Lee is Chief Scientific Officer of Lyell Immunopharma, Inc.. Currently has a direct ownership of 52,700 shares of LYEL, which is worth approximately $32,147. The most recent transaction as insider was on Feb 09, 2024, when has been sold 40,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
52.7K
0%
3M change
n/a
12M change
Total Value Held
$32,147
GKL
Gary K. Lee
Chief Scientific Officer
South San Francisco, CA